Talent was never the bottleneck

The claim from Ankur Capital's two report co-authors is that India's deep science constraint has migrated. Technology, Suraj argues, is now available to everybody, and talent is not the question — good research is happening in the universities. What is missing is everything between the bench and the market: commercialisation, industry participation, and above all infrastructure, because a startup that has proven something in a flask cannot find a 500- or 1,000-litre pilot facility to run it at scale. China's asset values, he says, are simply what happens when a country builds that layer first. The capital gap is the argument's second half: founders SaaS-ify their stories and quote ARR because the people writing cheques do not speak TRL, so a company that has genuinely derisked its technology has no vocabulary in which to say so. Ankur enters at TRL 4 or 5 — early prototype, lab-level data, never pure R&D — and funds the pilots, trials, regulatory filings and multi-geography patents that stand between a prototype and a product. The signs they offer that this is turning are unglamorous and specific: median cheque sizes rising, family offices and India's first corporate venture arms appearing, and Indian entities crossing half of all patents filed in India — which they insist is step one of defensibility, not proof of it. The unfinished work sits upstream, in a research system where high-quality work still fizzles out before it reaches the real world.